A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia

NCT04074551 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

145

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Dyslipidemias

Interventions

DRUG: HCP1701
DRUG: Losartan
DRUG: Amlodipine
DRUG: Rosuvastatin and Ezetimibe

Sponsor

Hanmi Pharmaceutical Company Limited